Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.
Jia LiStuart C GordonLoralee B RuppTalan ZhangSheri TrudeauScott D HolmbergAnne C MoormanPhilip R SpradlingEyasu H TeshaleJoseph A BoscarinoMark A SchmidtYihe G DaidaMei Lunull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Successful hepatitis C virus treatment among patients with type 2 diabetes significantly reduces HbA1c shortly after treatment, but these decreases are not sustained long-term. Less than three years after sustained virological response, haemoglobin A1c rebounds to levels similar to untreated/treatment failure patients, and higher than recommended for type 2 diabetic maintenance.